Filter Search for grants
Call Navigation
Deadline expired
The deadline for this call has expired.
Call key data
IPCEI Flagship Call: The Re-Industrialisation of Europe
Funding Program
European Institute of Innovation and Technology
deadlines
Opening
14.08.2024
Deadline
15.10.2024 16:00
Funding rate
50%
Call budget
€ 11,000,000.00
Estimated EU contribution per project
€ 1,000,000.00
Link to the call
Link to the submission
Call content
short description
As part of EIT Health's Flagship, 'The Re-Industrialisation of Europe', EIT Health is inviting you to submit your innovative solutions to support Med4Cure’s groundbreaking initiatives – and be part of an Important Project of Common European Interest (IPCEI).
Call objectives
EIT Health is looking for projects that focus on:
- Collecting, gathering, and studying bio-resources.
- Tools for better understanding disease biology and increasing medical translatability.
- Processing innovations through enhanced drug discovery, preclinical, and clinical procedures.
- Innovative production processes and tools towards sustainability and resilience across the health value chain.
This opportunity is best suited to proposals that feature digital tools, personalised medicine, or green manufacturing. EIT Health is open to other complementary and integrated activities that address the above critical workstreams.
Expected effects and impacts
To significantly boost growth, job creation, and the green and digital transition, it is crucial to unite knowledge, expertise and resources across the EU. This Flagship will support the deployment of innovative healthcare products and production processes for pharmaceuticals. It aims to accelerate medical advancement and foster the resilience of the EU health industry by enhancing drug discovery. It will have an expanded scope, addressing two challenges: a focus on equipping Europe with a strong, innovative and export-friendly healthcare industry, alongside developing lasting and innovative European manufacturing capabilities regarding critical products, notably pharmaceuticals. By focussing on unmet medical needs such as rare diseases and developing innovative and more sustainable production processes for pharmaceuticals, the projects supported by this Flagship will improve the quality of healthcare and increase the EU's preparedness for emerging health threats, while contributing to the green transition.
read more
Expected results
Please find further information about the three project areas below:
Digital Tools: Databases, tools to facilitate the use of clinical data, predictive model, federated data, in silico tools, etc.
IPCEI Med4Cure Workstreams:
- A: Collecting, gathering and studying bio-resources
- B: Tools for better understanding disease biology and increasing medical translatability
Example Complementary Activities:
- Bioinformatics and Data Analytics Platforms: Pilot a bioinformatics tool to manage and analyse initial datasets from biobanks, ensuring early functionality and usability
- In-Silico Drug Discovery: Develop computational models and simulations to predict the efficacy and safety of drug candidates, reducing the need for extensive laboratory testing
Personalised medicine: Diagnostic and early diagnostic, tools to facilitate improvements on current practices, AMR monitoring, genetic diversity, etc.
IPCEI Med4Cure Workstreams:
- B: Tools for better understanding disease biology and increasing medical translatability
- C: Processing innovations through enhanced drug discovery, preclinical and clinical procedures
Example Complementary Activities:
- Translational Research Models: Develop new organ-on-chip technologies to better replicate human disease conditions and improve the predictability of pre-clinical studies
- High-Throughput Screening Technologies: Develop/setup of high-throughput screening equipment. Provide training for researchers on using this equipment effectively to test a large number of compounds rapidly
Green manufacturing: Bioproduction tools, innovative production, digitalisation of production lines, etc.
IPCEI Med4Cure Workstreams:
- D: Innovative Production processes and tools towards sustainability and resilience across the health value chain
Example Complementary Activities:
- Sustainable Manufacturing Innovations: Feasibility study or pilot project to explore and implement sustainable practices/tools in pharmaceutical production, such as energy-efficient processes or water recycling systems
- Green Chemistry Initiatives: Develop and implement green chemistry protocols/tools to minimise the environmental impact of pharmaceutical manufacturing processes, including the reduction of hazardous waste and the use of renewable resources
read more
Eligibility Criteria
Regions / countries for funding
Moldova (Moldova), Albania (Shqipëria), Armenia (Հայաստան), Bosnia and Herzegovina (Bosna i Hercegovina / Босна и Херцеговина), Faeroes (Føroyar / Færøerne), Georgia (საქართველო), Iceland (Ísland), Israel (ישראל / إِسْرَائِيل), Kosovo (Kosova/Kosovë / Косово), Montenegro (Црна Гора), Morocco (المغرب), New Zealand (Aotearoa), North Macedonia (Северна Македонија), Norway (Norge), Serbia (Srbija/Сpбија), Switzerland (Schweiz/Suisse/Svizzera), Tunisia (تونس /Tūnis), Türkiye, Ukraine (Україна), United Kingdom
eligible entities
EU Body, Education and training institution, International organization, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), Other, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Research Institution incl. University, Small and medium-sized enterprise (SME)
Mandatory partnership
Yes
Project Partnership
The project consortia must include:
- Include one IPCEI direct partner/associated partner, one micro or small enterprise, and at least one academic organisation (research institute, university, hospital) or healthcare service provider
- Include participants residing in at least two eligible countries, participating through two different Co-Location Centres
- Involve organisations from two sides of the Knowledge Triangle, e.g., industry and healthcare provider, higher education institution and industry, etc
- Contribute to the EIT and EIT Health Dissemination and Promotion, and must follow the communication, dissemination, open science and visibility rules, including branding guidelines and obligations (set out in MGA Article 17). A communication, dissemination and outreach plan is required for each activity, including those providing financial support to third parties
- Complete the mandatory Ethical, Legal and Social Implications self-assessment checklist related to Horizon Europe in the EIT Health application system
To be eligible for funding, all applicants must be established in one of the Member States (MS) including their outermost regions, the Overseas Countries and Territories linked to the Member States or in countries associated to Horizon Europe as well as certain low- and middle-income countries.
Individuals cannot apply for funding under this call.
Non-EIT Health members will only be eligible to receive funding after they have acceded to the relevant EIT Health legal framework.
The provisions of the Articles of Association and By-Laws of the EIT Health association (EIT Health e.V) will apply to partners of selected activity consortiums. All project participants receiving funding on funded EIT Health projects must adhere to the EIT Health Fees as decided by the Partnership Assembly. Different membership fees apply depending on the size and nature of the organisation and the annual EIT Funding requested for that organisation as part of the project. For more information on the fee model please check our website section here and the supporting documents.
It is not required that IPCEI Med4Cure direct or associated partner not receiving funding from EIT Health apply for EIT Health membership to participate in a project consortium.
Above and beyond the specific EIT Health rules of participation, all activities must comply with the relevant Horizon Europe and EIT financial and legal framework considerations.
other eligibility criteria
To be considered for this call, proposed solutions must have a minimum Innovation Maturity Level IML 7 (Validation of Solution) and demonstrate how the funding will be utilised to reach the market within 1 year after the end of the project.
Selected projects will receive a grant of up to € 1million per project and must utilise the financial resources by 31 December 2025. The micro or small enterprise’s grant is of a minimum of 400K€ and a maximum of 500K€.
Additional information
Topics
Relevance for EU Macro-Region
EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region
UN Sustainable Development Goals (UN-SDGs)
Additional Information
The application will be done through the EIT Health Application Platform. New applicants will need to register on the application platform.
If the applicant is already an EIT Health member, or has registered as an External project Partner in previous Call(s) on our platform PLAZA, the corresponding data for the organisation will be available in the application platform.
However, the applicant will still need to create a new account as an individual and link themselves to their organisation.
The approval of this link might take up to 48 hours and extra information on the organisation profile might be requested.
Call documents
EIT Health Call Document- IPCEI Flagship CallEIT Health Call Document- IPCEI Flagship Call(611kB)
Contact
To see more information about this call, you can register for free here
or log in with an existing account.
Log in
Register now